1. Adjuvant avelumab in merkel cell cancer. https://ClinicalTrials.gov/show/NCT03271372. Accessed 8 Feb 2020
2. Adjuvant therapy of completely resected merkel cell carcinoma with immune checkpoint blocking antibodies vs observation. https://ClinicalTrials.gov/show/NCT02196961. Accessed 8 Feb 2020
3. Avelumab in subjects with merkel cell carcinoma (JAVELIN merkel 200). https://ClinicalTrials.gov/show/NCT02155647. Accessed 8 Feb 2020
4. (2017) Current clinical trials for MCC. https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/merkel-cell/treatment. Accessed 14 Jan 2020
5. Gene-modified immune cells (FH-MCVA2TCR) in treating patients with metastatic or unresectable merkel cell cancer. https://ClinicalTrials.gov/show/NCT03747484. Accessed 8 Feb 2020